1.1 A bill for an act
1.2 relating to cannabis; requiring health care facilities to accommodate cannabis and
1.3 hemp products; amending Minnesota Statutes 2024, section 342.56, subdivision
1.4 2.
1.5BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:
1.6 Section 1. Minnesota Statutes 2024, section 342.56, subdivision 2, is amended to read:
1.7 Subd. 2.Health care facilities.(a) Health care facilities licensed under chapter 144A;
1.8hospice providers licensed under chapter 144A; boarding care homes or supervised living
1.9facilities licensed under section 144.50; assisted living facilities under chapter 144G; facilities
1.10owned, controlled, managed, or under common control with hospitals licensed under chapter
1.11144; and other health care facilities licensed by the commissioner of health or the
1.12commissioner of human services may adopt reasonable restrictions on the use of medical
1.13cannabis flower or medical, cannabinoid products, lower-potency hemp edibles, hemp-derived
1.14consumer products, or hemp-derived topical products by a patient enrolled in the registry
1.15program who resides at or is actively receiving treatment or care at the facility. The
1.16restrictions may include a provision that the facility must not store or maintain a patient's
1.17supply of medical cannabis flower or medical cannabinoid products on behalf of the patient;
1.18that a patient store the patient's supply of medical cannabis flower or medicinal, cannabinoid
1.19products, lower-potency hemp edibles, hemp-derived consumer products, or hemp-derived
1.20topical products in a locked container accessible only to the patient, the patient's designated
1.21caregiver, or the patient's parent, legal guardian, or spouse; that the facility is not responsible
1.22for providing medical cannabis or hemp for patients; and that medical cannabis flower or
1.23medical, cannabinoid products, lower-potency hemp edibles, hemp-derived consumer
1.24products, or hemp-derived topical products are used only in a location specified by the
1Section 1.
25-04960 as introduced03/20/25 REVISOR SS/LJ
SENATE
STATE OF MINNESOTA
S.F. No. 3349NINETY-FOURTH SESSION
(SENATE AUTHORS: CLARK)
OFFICIAL STATUSD-PGDATE
Introduction and first reading04/09/2025
Referred to Commerce and Consumer Protection 2.1facility or provider. Nothing in this subdivision requires facilities and providers listed in
2.2this subdivision to adopt such restrictions.
2.3 (b) No facility or provider listed in this subdivision may unreasonably limit a patient's
2.4access to or use of medical cannabis flower or medical cannabinoid products, lower-potency
2.5hemp edibles, hemp-derived consumer products, or hemp-derived topical products to the
2.6extent that such use is authorized under sections 342.51 to 342.59, or the patient is a visiting
2.7patient authorized to use medical cannabis under the laws of their state of residence. No
2.8facility or provider listed in this subdivision may prohibit a patient access to or use of medical
2.9cannabis flower or medical cannabinoid products due solely to the fact that cannabis is a
2.10controlled substance pursuant to the federal Uniform Controlled Substances Act. If a federal
2.11regulatory agency, the United States Department of Justice, or the federal Centers for
2.12Medicare and Medicaid Services takes one of the following actions, a facility or provider
2.13may suspend compliance with this paragraph until the regulatory agency, the United States
2.14Department of Justice, or the federal Centers for Medicare and Medicaid Services notifies
2.15the facility or provider that it may resume permitting the use of medical cannabis flower or
2.16medical, cannabinoid products, lower-potency hemp edibles, hemp-derived consumer
2.17products, or hemp-derived topical products within the facility or in the provider's service
2.18setting:
2.19 (1) a federal regulatory agency or the United States Department of Justice initiates
2.20enforcement action against a facility or provider related to the facility's compliance with
2.21the medical cannabis program; or
2.22 (2) a federal regulatory agency, the United States Department of Justice, or the federal
2.23Centers for Medicare and Medicaid Services issues a rule or otherwise provides notification
2.24to the facility or provider that expressly prohibits the use of medical cannabis in health care
2.25facilities or otherwise prohibits compliance with the medical cannabis program.
2.26 (c) An employee or agent of a facility or provider listed in this subdivision or a person
2.27licensed under chapter 144E is not violating this chapter or chapter 152 for the possession
2.28of medical cannabis flower or medical cannabinoid products while carrying out employment
2.29duties, including providing or supervising care to a patient enrolled in the registry program,
2.30or distribution of medical cannabis flower or medical cannabinoid products to a patient
2.31enrolled in the registry program who resides at or is actively receiving treatment or care at
2.32the facility or from the provider with which the employee or agent is affiliated.
2.33 (d) Nothing in this subdivision is intended to require a facility covered by this subdivision
2.34to permit violations of sections 144.411 to 144.417.
2Section 1.
25-04960 as introduced03/20/25 REVISOR SS/LJ